BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24970021)

  • 1. The impact of pathologic nodal status on survival following neoadjuvant chemoradiation for locally advanced rectal cancer.
    Hernandez JM; Clark W; Weber J; Fulp WJ; Lange L; Shibata D
    Int J Colorectal Dis; 2014 Sep; 29(9):1061-8. PubMed ID: 24970021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy.
    Abdel-Misih SR; Wei L; Benson AB; Cohen S; Lai L; Skibber J; Wilkinson N; Weiser M; Schrag D; Bekaii-Saab T
    J Natl Compr Canc Netw; 2016 Dec; 14(12):1528-1534. PubMed ID: 27956537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival.
    Theodoropoulos G; Wise WE; Padmanabhan A; Kerner BA; Taylor CW; Aguilar PS; Khanduja KS
    Dis Colon Rectum; 2002 Jul; 45(7):895-903. PubMed ID: 12130878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
    Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of neoadjuvant chemoradiation in locally advanced rectal cancer at a tertiary hospital.
    Yeung WW; Ma BB; Lee JF; Ng SS; Cheung MH; Ho WM; Tsang MW; Chu S; Lam DC; Mo FK
    Hong Kong Med J; 2016 Dec; 22(6):546-55. PubMed ID: 27795447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
    Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of persistent lymph node involvement after neoadjuvant therapy for stage III rectal cancer.
    Dinaux AM; Leijssen L; Bordeianou LG; Kunitake H; Amri R; Berger DL
    Surgery; 2018 Apr; 163(4):784-788. PubMed ID: 29277386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
    Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
    Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Different Nodal Staging in Patients With Locally Advanced Mid-low Rectal Cancer After Long-term Neoadjuvant Chemoradiation Therapy.
    Petrucciani N; Carra MC; Martínez-Pérez A; Vitali GC; Landi F; Genova P; Memeo R; Brunetti F; Espin E; Ris F; De'angelis N;
    Anticancer Res; 2019 Apr; 39(4):2113-2120. PubMed ID: 30952757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
    BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status.
    Kulaylat AS; Hollenbeak CS; Stewart DB
    Ann Surg Oncol; 2017 May; 24(5):1281-1288. PubMed ID: 27864695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant-intensified treatment for rectal cancer: time to change?
    Musio D; De Felice F; Bulzonetti N; Guarnaccia R; Caiazzo R; Bangrazi C; Raffetto N; Tombolini V
    World J Gastroenterol; 2013 May; 19(20):3052-61. PubMed ID: 23716984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
    Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
    Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy.
    Park IJ; Yu CS; Lim SB; Yoon YS; Kim CW; Kim TW; Kim JH; Kim JC
    World J Gastroenterol; 2015 Mar; 21(11):3274-81. PubMed ID: 25805934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy.
    Huebner M; Wolff BG; Smyrk TC; Aakre J; Larson DW
    World J Surg; 2012 Mar; 36(3):675-83. PubMed ID: 22270980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy?
    Kiran RP; Kirat HT; Burgess AN; Nisar PJ; Kalady MF; Lavery IC
    Ann Surg Oncol; 2012 Apr; 19(4):1206-12. PubMed ID: 21935748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic outcomes of neoadjuvant chemoradiation for locally advanced rectal cancer: a single-institution experience.
    Leong YH; Leong CN; Tay GS; Sim R; Lopes G; Low W; Choo BA; Tey J
    Ann Acad Med Singap; 2014 Dec; 43(12):569-75. PubMed ID: 25588915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.
    Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT
    Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The local immune phenotype influences prognosis in patients with nodal-positive rectal cancer after neoadjuvant chemoradiation.
    Schollbach J; Kircher S; Wiegering A; Anger F; Rosenwald A; Germer CT; Löb S
    Int J Colorectal Dis; 2020 Feb; 35(2):365-370. PubMed ID: 31828368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interval between neoadjuvant treatment and definitive surgery in locally advanced rectal cancer: impact on response and oncologic outcomes.
    Calvo FA; Morillo V; Santos M; Serrano J; Gomez-Espí M; Rodriguez M; Del Vale E; Gracia-Sabrido JL; Ferrer C; Sole C
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1651-60. PubMed ID: 24880919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.